In other words, during the current ceRNA network, NR2F1-AS1 and VAMP7 played oncogenic roles in GC, while increasing studies have reported that miR-29a-3p exerted tumor-suppressive roles in GC [23–26]. This evidence concerns the gene NR2F1 and neoplasm.